Improved Relapse-Free Survival (RFS) for Pediatric and Young Adult Patients with Relapsed or Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (B-ALL) and Low or Intermediate Preinfusion Disease Burden Treated with Tisagenlecleucel: Results from the CIBMTR Registry

Authors:
  • SJSamuel John
    Samuel John
  • MHMichael Heim
    Michael Heim
  • KCKevin J. Curran
    Kevin J. Curran
  • EHErin M. Hall
    Erin M. Hall
  • AKAmy K. Keating
    Amy K. Keating
  • SBSusanne H.C. Baumeister
    Susanne H.C. Baumeister
  • SNSarah Nikiforow
    Sarah Nikiforow
  • TDTimothy Driscoll
    Timothy Driscoll
  • AMAmy Moskop
    Amy Moskop
  • KMKevin O. McNerney
    Kevin O. McNerney
  • CPChristine L Phillips
    Christine L Phillips
  • MPMichael Pulsipher
    Michael Pulsipher

Abstract
No abstract available